Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter

J Biol Chem. 2001 Dec 14;276(50):46822-9. doi: 10.1074/jbc.M104612200. Epub 2001 Oct 4.

Abstract

The enterohepatic circulation is essential for the maintenance of bile acids and cholesterol homeostasis. The ileal bile acid transporter on the apical membrane of enterocytes mediates the intestinal uptake of bile salts, but little is known about the bile salt secretion from the basolateral membrane of enterocytes into blood. In the basolateral membrane of enterocytes, an ATP-binding cassette transporter, multidrug resistance protein 3 (MRP3), is expressed, which has the ability to transport bile salts. We hypothesized that MRP3 might play a role in the enterohepatic circulation of bile salts by transporting them from enterocytes into circulating blood through the up-regulation of MRP3 expression, so we investigated the transcriptional control of MRP3 in response to bile salts. MRP3 mRNA levels were increased about 3-fold in human colon cells by chenodeoxycholic acid (CDCA), in a dose- and time-dependent manner. In the promoter assay, the promoter activity of MRP3 was increased about 3-fold over the basal promoter activity when treated with CDCA, and the putative bile salt-responsive elements exist in the region -229/-138 including two alpha-1 fetoprotein transcription factor (FTF)-like elements. Constructs with a specific mutation in the consensus sequence of FTF elements showed no increase in basal transcriptional activity following CDCA treatment. In electrophoretic mobility shift assay with nuclear extracts, specific binding of FTF to FTF-like elements was observed when treated with CDCA. The expression of FTF mRNA levels were also markedly enhanced in response to CDCA, and overexpression of FTF specifically activated the MRP3 promoter activity about 4-fold over the basal promoter activity. FTF thus might play a key role not only in the bile salt synthetic pathway in hepatocytes but also in the bile salt excretion pathway in enterocytes through the regulation of MRP3 expression. MRP3 may contribute as a plausible bile salt-exporting transporter to the enterohepatic circulation of bile salts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5' Untranslated Regions
  • ATP Binding Cassette Transporter, Subfamily B / biosynthesis*
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / biosynthesis
  • ATP-Binding Cassette Transporters / biosynthesis*
  • Animals
  • Bile Acids and Salts / metabolism*
  • Binding, Competitive
  • Blotting, Northern
  • COS Cells
  • Cell Nucleus / metabolism
  • Chenodeoxycholic Acid / pharmacology
  • Cloning, Molecular
  • DNA, Complementary / metabolism
  • Dose-Response Relationship, Drug
  • Enterocytes / metabolism*
  • Gastrointestinal Agents / pharmacology
  • Genes, Reporter
  • Hepatocytes / metabolism
  • Humans
  • Luciferases / metabolism
  • Mitochondrial Proteins*
  • Models, Biological
  • Models, Genetic
  • Plasmids / metabolism
  • Promoter Regions, Genetic
  • Protein Binding
  • RNA / metabolism
  • RNA, Messenger / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Ribosomal Proteins / biosynthesis
  • Saccharomyces cerevisiae Proteins*
  • Time Factors
  • Transcription, Genetic
  • Transfection
  • Tumor Cells, Cultured
  • Up-Regulation

Substances

  • 5' Untranslated Regions
  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • ATP-Binding Cassette Transporters
  • Bile Acids and Salts
  • DNA, Complementary
  • Gastrointestinal Agents
  • MRP2 protein, S cerevisiae
  • Mitochondrial Proteins
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • Ribosomal Proteins
  • Saccharomyces cerevisiae Proteins
  • Chenodeoxycholic Acid
  • RNA
  • multidrug resistance protein 3
  • Luciferases